23andMe Receives FDA Approval for Inherited Colorectal Cancer Risk Report

The second ever direct-to-consumer genetic health risk report for inherited cancers was just approved by the US Food and Drug Administration (FDA). Soon, consumers can see if they carry the genes responsible for hereditary colorectal cancer (syndrome), thanks to the personal genomics and biotechnology giant, 23andMe.